Royce & Associates’s Aceragen Inc ACGN Stock Holding History

Royce & Associates’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,419	Closed	-$213K	–	1080
2020 Q4	$213K	Hold	3,419	–	–	﹤0.01%	960
2020 Q3	$124K	Hold	3,419	–	–	﹤0.01%	956
2020 Q2	$104K	Hold	3,419	–	–	﹤0.01%	979
2020 Q1	$77K	Hold	3,419	–	–	﹤0.01%	981
2019 Q4	$106K	Hold	3,419	–	–	﹤0.01%	993
2019 Q3	$168K	Hold	3,419	–	–	﹤0.01%	984
2019 Q2	$155K	Hold	3,419	–	–	﹤0.01%	1000
2019 Q1	$148K	Hold	3,419	–	–	﹤0.01%	1008
2018 Q4	$161K	Hold	3,419	–	–	﹤0.01%	988
2018 Q3	$517K	Hold	3,419	–	–	﹤0.01%	976
2018 Q2	$613K	Hold	3,419	–	–	﹤0.01%	1005
2018 Q1	$855K	Hold	3,419	–	–	0.01%	993
2017 Q4	$980K	Hold	3,419	–	–	0.01%	980
2017 Q3	$1.04M	Hold	3,419	–	–	0.01%	952
2017 Q2	$799K	Hold	3,419	–	–	0.01%	1003
2017 Q1	$1.15M	Buy	+3,419	New	+$825K	0.01%	961

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royce & Associates's ACGN Position: Q1 2021 in Review

Royce & Associates sold out of Aceragen Inc (ACGN) in Q1 2021, closing a stake of 3,419 shares — an estimated $213K sold.

Royce & Associates first reported a position in ACGN in Q1 2017 and held it in 16 quarters. The position peaked at $1.15M in Q1 2017. 56 funds tracked by Wall St. Rank hold ACGN as of Q1 2021.

Royce & Associates reported no remaining Aceragen Inc position as of Q1 2021 after selling out during the quarter.
Royce & Associates sold 3,419 Aceragen Inc shares in Q1 2021, an estimated $213K.
Royce & Associates first reported a position in Aceragen Inc in Q1 2017 and held it in 16 quarters.
Royce & Associates's Aceragen Inc position peaked at $1.15M in Q1 2017.
56 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2021.

Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.